KIR2DL3, Killer cell immunoglobulin-like receptor 2DL3 is a transmembrane glycoprotein expressed by the natural killer cells and the subsets of the T cells. The KIR genes are polymorphic, which means that they have many different alleles. The KIR genes are also extremely homologous, which means that they are similar in position, structure and evolutionary origin, but not necessarily in function.
Natural killer (NK) cells are an important component of innate antiviral immune response. Have the ability to lyse target cells without prior sensitization antigen and regulate the immune responses by secreting chemokine adaptive and cytokines. Activation of NK cells is determined by integration of inhibitory signals and activating issued by several families of different receptors, including killer cell immunoglobulin-like receptors (KIR) that predominantly recognize antigens of class I human leukocyte antigen ( HLA).[4]
Structure and location
The genes responsible for coding of KIR proteins are found along the 19th chromosome section 19q 13.4 within the 1Mb Leukocyte Receptor Complex (LRC). The subsets of the KIR proteins are classified by their number of extracellular IG domains and by whether they have a long (L) or short (S) cytoplasmic domain-tail. The number coming at the end of the name of protein classifies it as a branch of the subset it belongs to.[5][6][7]
Function
The protein KIR2DL3 has long tailed cytoplasmic domain and transduce the inhibitory signal upon the ligand binding via an immunoreceptor tyrosine-based inhibitory motif (ITIM). The ligands of the protein is a subset of HLA-C molecules: HLA-Cw1, HLA-Cw3, HLA-Cw7. The protein is thought to play an important role in regulating of the immune responses. The HLA-C molecules are human leukocyte antigens and are the gene complexes to encode major histocompatibility complex (MHC) proteins in humans. HLA are polymorphic, thus the MHCs of humans differ from an individual to another. KIR2DL3 is a protein complex of two extracellular domains and a long tailed endo-cellular cytoplasmatic tail, which assign it in charge of sending inhibitory signals throughout the cell.[8]
Pathology
The protein KIR2DL3 transduces inhibitory signals upon the ligand binding via an immune tyrosine-based inhibitory motif (ITIM) to its long inner cytoplasmic tail. The tyrosine kinase based transductions are enzymatic transferences of a phosphate group from an ATP molecule to a protein in the cell. Thus functioning as an ' on ' and ' off ' switch in many cellular functions. Tyrosine Kinases are a sub-class of the protein-kinase. Phosphorylation of proteins is a necessary step in transduction of signals within a cell in order to regulate the cellular activity. Protein Kinases might get stuck in ' off ' position and inhibit the cell reproduction for good, or on the contrary might get stuck in ' on 'position, thus rendering the cell to reproduce unregulatedly, which is a necessary step for the development of cancer.[9][10][11]
References
- 1 2 3 ENSG00000274830, ENSG00000283790, ENSG00000277554, ENSG00000274952, ENSG00000284504, ENSG00000278369, ENSG00000278327, ENSG00000284510, ENSG00000277924, ENSG00000276459, ENSG00000283702, ENSG00000274402, ENSG00000284241, ENSG00000277484, ENSG00000273887, ENSG00000275623, ENSG00000243772, ENSG00000276218, ENSG00000275658, ENSG00000273947, ENSG00000274108, ENSG00000284333, ENSG00000284044, ENSG00000277317, ENSG00000284236, ENSG00000284132, ENSG00000276590, ENSG00000275008, ENSG00000274410, ENSG00000283996 GRCh38: Ensembl release 89: ENSG00000283708, ENSG00000274830, ENSG00000283790, ENSG00000277554, ENSG00000274952, ENSG00000284504, ENSG00000278369, ENSG00000278327, ENSG00000284510, ENSG00000277924, ENSG00000276459, ENSG00000283702, ENSG00000274402, ENSG00000284241, ENSG00000277484, ENSG00000273887, ENSG00000275623, ENSG00000243772, ENSG00000276218, ENSG00000275658, ENSG00000273947, ENSG00000274108, ENSG00000284333, ENSG00000284044, ENSG00000277317, ENSG00000284236, ENSG00000284132, ENSG00000276590, ENSG00000275008, ENSG00000274410, ENSG00000283996 - Ensembl, May 2017
- ↑ "Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
- ↑ "KIR2DL3 - Killer cell immunoglobulin-like receptor 2DL3 precursor - Homo sapiens (Human) - KIR2DL3 gene & protein". www.uniprot.org. Retrieved 2018-11-18.
- ↑ Hölzemer A, Thobakgale CF, Jimenez Cruz CA, Garcia-Beltran WF, Carlson JM, van Teijlingen NH, et al. (November 2015). "Selection of an HLA-C*03:04-Restricted HIV-1 p24 Gag Sequence Variant Is Associated with Viral Escape from KIR2DL3+ Natural Killer Cells: Data from an Observational Cohort in South Africa". PLOS Medicine. 12 (11): e1001900, discussion e1001900. doi:10.1371/journal.pmed.1001900. PMC 4648589. PMID 26575988.
- ↑ Hölzemer A, Thobakgale CF, Jimenez Cruz CA, Garcia-Beltran WF, Carlson JM, van Teijlingen NH, et al. (November 2015). "Selection of an HLA-C*03:04-Restricted HIV-1 p24 Gag Sequence Variant Is Associated with Viral Escape from KIR2DL3+ Natural Killer Cells: Data from an Observational Cohort in South Africa". PLOS Medicine. 12 (11): e1001900, discussion e1001900. doi:10.1371/journal.pmed.1001900. PMC 4648589. PMID 26575988.
- ↑ Frazier WR, Steiner N, Hou L, Dakshanamurthy S, Hurley CK (June 2013). "Allelic variation in KIR2DL3 generates a KIR2DL2-like receptor with increased binding to its HLA-C ligand". Journal of Immunology. 190 (12): 6198–6208. doi:10.4049/jimmunol.1300464. PMC 3679298. PMID 23686481.
- ↑ Lunemann S, Martrus G, Hölzemer A, Chapel A, Ziegler M, Körner C, et al. (August 2016). "Sequence variations in HCV core-derived epitopes alter binding of KIR2DL3 to HLA-C∗03:04 and modulate NK cell function". Journal of Hepatology. 65 (2): 252–258. doi:10.1016/j.jhep.2016.03.016. PMC 4955726. PMID 27057987.
- ↑ Sim MJ, Stowell J, Sergeant R, Altmann DM, Long EO, Boyton RJ (January 2016). "KIR2DL3 and KIR2DL1 show similar impact on licensing of human NK cells". European Journal of Immunology. 46 (1): 185–191. doi:10.1002/eji.201545757. PMC 4737201. PMID 26467237.
- ↑ Gendzekhadze K, Norman PJ, Abi-Rached L, Graef T, Moesta AK, Layrisse Z, Parham P (November 2009). "Co-evolution of KIR2DL3 with HLA-C in a human population retaining minimal essential diversity of KIR and HLA class I ligands". Proceedings of the National Academy of Sciences of the United States of America. 106 (44): 18692–18697. Bibcode:2009PNAS..10618692G. doi:10.1073/pnas.0906051106. PMC 2774017. PMID 19837691.
- ↑ Roberts CH, Molina S, Makalo P, Joof H, Harding-Esch EM, Burr SE, et al. (March 2014). "Conjunctival scarring in trachoma is associated with the HLA-C ligand of KIR and is exacerbated by heterozygosity at KIR2DL2/KIR2DL3". PLOS Neglected Tropical Diseases. 8 (3): e2744. doi:10.1371/journal.pntd.0002744. PMC 3961204. PMID 24651768.
- ↑ Isitman G, Tremblay-McLean A, Lisovsky I, Bruneau J, Lebouché B, Routy JP, Bernard NF (2016-10-12). "NK Cells Expressing the Inhibitory Killer Immunoglobulin-Like Receptors (iKIR) KIR2DL1, KIR2DL3 and KIR3DL1 Are Less Likely to Be CD16+ than Their iKIR Negative Counterparts". PLOS ONE. 11 (10): e0164517. Bibcode:2016PLoSO..1164517I. doi:10.1371/journal.pone.0164517. PMC 5061331. PMID 27732638.